Skip to main content

Harry Leider, M.D., M.B.A.

Equibles does not estimate personal net worth.

Get an email with a short summary when Zeo ScientifiX, Inc. publishes a filing, an earnings call transcript or a press release.

Get ZEOX alerts

About Harry Leider, M.D., M.B.A.

Harry Leider, M.D., M.B.A. is recorded as CEO and Board Member at Zeo ScientifiX, Inc. (ZEOX) since June 6, 2023. Zeo ScientifiX, Inc. reported in an 8-K filed June 6, 2023 that Harry Leider, M.D., M.B.A. was appointed a member of the board of directors, effective June 6, 2023. Zeo ScientifiX, Inc. reported in an 8-K filed June 6, 2023 that Harry Leider, M.D., M.B.A. was appointed Chief Executive Officer, effective June 6, 2023. Zeo ScientifiX, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Zeo ScientifiX, Inc. includes Harry Leider (CEO), Ian Bothwell (CEO and Board Member), Ian T. Bothwell (CEO) and 7 others.

“On June 6, 2023, our board of directors appointed Harry Leider, M.D., M.B.A., as Chief Executive Officer and a member of the board of directors and Howard J. Golub, M.D., as Executive Vice President and Chief Science Officer.”
Zeo ScientifiX, Inc. Form 8-K, filed June 6, 2023 · Read the filing
“On June 6, 2023, our board of directors appointed Harry Leider, M.D., M.B.A., as Chief Executive Officer and a member of the board of directors and Howard J. Golub, M.D., as Executive Vice President and Chief Science Officer.”
Zeo ScientifiX, Inc. Form 8-K, filed June 6, 2023 · Read the filing

Affiliation history

Company network

Leadership on record at Zeo ScientifiX, Inc.

Recent activity